Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine With or Without Adavosertib in Recurrent Ovarian Cancer
NCT02101775Phase 2Active, not recruiting
- Sponsor
- National Cancer Institute
- Start
- Jul 2014
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of adavosertib in ovarian cancer, primary peritoneal cancer (PPC), fallopian tube cancer (PFTC), sponsored by National Cancer Institute. Started Jul 2014; status: active, not recruiting.
02
Drugs
adavosertib
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)fallopian tube cancer (PFTC)
Beyond the preview
Go deeper on NCT02101775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02101775.